Here are four things to know.
1. Pfizer’s consumer health business, which has been for sale for months, includes products such as Advil, Chapstick and Centrum vitamins.
2. P&G is offering around $15 billion for the consumer health business, while Pfizer is seeking at least $20 billion, sources familiar with the discussions told CNBC.
3. Johnson & Johnson, GlaxoSmithKline and Reckitt Benckiser Group already looked at purchasing Pfizer’s consumer health business.
4. Pfizer is also considering other options for the business, including a joint venture with other pharmaceutical companies. The drugmaker hopes to reach a decision on the consumer health business by May.
More articles on supply chain:
Study: 40% of providers have canceled surgeries over supply shortages
10 immensely overinflated hospital costs
Beating Amazon to the punch: Zipline launches drone to deliver medical supplies at 79 mph
